CompletedPhase 2

Study of ATH434 in Participants with Multiple System Atrophy

United States, Australia, France77 participantsStarted 2022-07-01

Plain-language summary

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Who can participate

Age range

30 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Participant has clinical features of parkinsonism.
. Participant has evidence of orthostatic hypotension and/or bladder dysfunction.
. Participant has ataxia and/or pyramidal signs on neurological examination.
. Participant is ambulatory.
. Participant has biomarker evidence of MSA in biologic fluid and on MRI.

Exclusion criteria

. Participant has motor symptoms for \> 4 years.
. Participant has advanced disease, as indicated by frequent falls or choking.
. Participant has structural brain abnormality on MRI.
. Participant has any significant neurological disorder other than MSA.
. Participant has an unstable medical or psychiatric illness.
. Participant has a contraindication to, or is unable to tolerate, MRI or lumbar puncture.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in iron content as measured by brain MRI

Timeframe: Change from Baseline to Week 52

Trial details

NCT IDNCT05109091

SponsorAlterity Therapeutics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-11-28

View on ClinicalTrials.gov More Multiple System Atrophy trials